Hikma Pharmaceutical reported $1.11B in Stock for its fiscal semester ending in December of 2025.





Stock Change Date
Almirall EUR 173.45M 4.68M Jun/2026
argenx SE USD 371M 102.53M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
Autolus Therapeutics Ltd USD 35.02M 1.58M Sep/2026
Bayer EUR 11.97B 43M Jun/2026
Fresenius EUR 2.77B 43M Jun/2026
Genmab DKK 21M 8M Mar/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
GRIFOLS EUR 3.47B 23M Sep/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.89B 104M Jun/2026
Orion EUR 545.5M 33.3M Sep/2026
Recordati EUR 550.34M 4.52M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024